has been cited by the following article(s):
|
[1]
|
Nanotherapeutics to Overcome Chemotherapy Resistance in Ovarian Cancer
Pharmaceutical Research,
2026
DOI:10.1007/s11095-026-04020-8
|
|
|
|
|
[2]
|
Novel Polymorphic Patterns for Elacestrant Dihydrochloride
Pharmaceutics,
2025
DOI:10.3390/pharmaceutics17060745
|
|
|
|
|
[3]
|
Evaluation of breast cancer symptoms and risk factors in women: the case of Türkiye
Revista da Escola de Enfermagem da USP,
2025
DOI:10.1590/1980-220x-reeusp-2025-0240en
|
|
|
|
|
[4]
|
Evaluación de los síntomas y factores de riesgo del cáncer de mama en mujeres: el caso de Turquía
Revista da Escola de Enfermagem da USP,
2025
DOI:10.1590/1980-220x-reeusp-2025-0240es
|
|
|
|
|
[5]
|
Addressing social and economic disparities in triple-negative breast cancer immunotherapy: a U.S.-focused review
Immunotherapy,
2025
DOI:10.1080/1750743X.2025.2597138
|
|
|
|
|
[6]
|
Recent findings on the PD-1/PD-L1 Axis in breast cancer: Molecular mechanisms, immunotherapeutic potentials, and clinical implications
Critical Reviews in Oncology/Hematology,
2025
DOI:10.1016/j.critrevonc.2025.104989
|
|
|
|